|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85.34 EUR | +0.91% |
|
-0.54% | -9.00% |
| Capitalization | 103B 120B 96.24B 89.88B 167B 10,780B 181B 1,129B 436B 5,093B 450B 441B 18,572B | P/E ratio 2025 * |
12.3x | P/E ratio 2026 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise value | 115B 134B 108B 101B 187B 12,071B 203B 1,264B 488B 5,704B 504B 494B 20,797B | EV / Sales 2025 * |
2.65x | EV / Sales 2026 * | 2.43x |
| Free-Float |
87.31% | Yield 2025 * |
4.92% | Yield 2026 * | 5.07% |
Last Transcript: Sanofi
| 1 day | +1.40% | ||
| 1 week | -0.01% | ||
| Current month | -0.01% | ||
| 1 month | +0.61% | ||
| 3 months | +7.86% | ||
| 6 months | -1.99% | ||
| Current year | -8.52% |
| 1 week | 84.3 |  | 87.25 |
| 1 month | 84.3 | | 90.79 |
| Current year | 76.15 | | 110.88 |
| 1 year | 76.15 | | 110.88 |
| 3 years | 76.15 | | 110.88 |
| 5 years | 74.92 | | 110.88 |
| 10 years | 62.5 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 58 | 2019-08-31 |
| Director of Finance/CFO | 63 | 2024-03-31 | |
Madeleine Roach
COO | Chief Operating Officer | 41 | 2023-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 72 | 2014-04-30 |
| Director/Board Member | 60 | 2019-04-29 | |
Paul Hudson
BRD | Director/Board Member | 58 | 2019-10-29 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 3.66% | 150 M€ | +18.26% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.40% | -0.01% | -6.59% | -0.22% | 120B | |
| -1.85% | -8.14% | +22.25% | +170.70% | 908B | |
| -1.39% | -2.45% | +34.57% | +13.19% | 488B | |
| -0.66% | +0.46% | +29.61% | +39.75% | 404B | |
| +1.14% | +2.05% | +22.40% | +1.34% | 331B | |
| +0.73% | -2.50% | +28.31% | +20.99% | 280B | |
| +0.86% | +3.18% | +19.27% | +25.64% | 256B | |
| -1.35% | -3.57% | -0.47% | -8.32% | 250B | |
| +2.64% | -0.80% | -59.22% | -30.17% | 212B | |
| -1.52% | -1.28% | +22.25% | +19.14% | 183B | |
| Average | +0.55% | -1.93% | +11.24% | +25.21% | 343.3B | |
| Weighted average by Cap. | +0.46% | -3.04% | +17.45% | +54.02% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 43.48B 50.7B 40.66B 37.98B 70.71B 4,555B 76.59B 477B 184B 2,152B 190B 186B 7,847B | 46.51B 54.24B 43.49B 40.62B 75.63B 4,872B 81.93B 510B 197B 2,302B 204B 199B 8,393B |
| Net income | 8.33B 9.72B 7.79B 7.28B 13.55B 873B 14.68B 91.42B 35.28B 412B 36.47B 35.69B 1,504B | 8.32B 9.7B 7.78B 7.27B 13.53B 871B 14.66B 91.27B 35.22B 412B 36.41B 35.64B 1,501B |
| Net Debt | 12.33B 14.38B 11.53B 10.77B 20.05B 1,291B 21.72B 135B 52.2B 610B 53.96B 52.81B 2,225B | 9.91B 11.55B 9.27B 8.65B 16.11B 1,038B 17.45B 109B 41.95B 490B 43.37B 42.44B 1,788B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 85.34 € | +0.91% | 970,456 |
| 25-12-04 | 84.57 € | -1.25% | 2,217,125 |
| 25-12-03 | 85.64 € | -0.59% | 1,447,788 |
| 25-12-02 | 86.15 € | -0.51% | 1,205,255 |
| 25-12-01 | 86.59 € | +0.97% | 2,021,650 |
Real-time Euronext Paris, December 05, 2025 at 08:31 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition